Clinical trial

Biomarkers of Synaptic Damage in Multiple Sclerosis

NCT03217396

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2017-11-22

PhaseN/A

Study timeline

Study start (actual)2017-11-22Date precision: day

Registry last updated2022-10-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Parkinson Diseaseunresolved

Amyotrophic Lateral Sclerosisunresolved

Alzheimer Diseaseunresolved

Interventions

lumbar puncturePROCEDURE

Sponsors & collaborators

Neuromed IRCCSlead sponsor

IRCCS Multimedicacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03217396 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.